Literature DB >> 29138281

A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo.

Farah H Bardai1, Liqun Wang1, Yamini Mutreja2, Mythili Yenjerla2, T Chris Gamblin3, Mel B Feany4.   

Abstract

The microtubule binding protein tau is strongly implicated in multiple neurodegenerative disorders, including frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), which is caused by mutations in tau. In vitro, FTDP-17 mutant versions of tau can reduce microtubule binding and increase the aggregation of tau, but the mechanism by which these mutations promote disease in vivo is not clear. Here we take a combined biochemical and in vivo modeling approach to define functional properties of tau driving neurotoxicity in vivo We express wild-type human tau and five FTDP-17 mutant forms of tau in Drosophila using a site-directed insertion strategy to ensure equivalent levels of expression. We then analyze multiple markers of neurodegeneration and neurotoxicity in transgenic animals, including analysis of both males and females. We find that FTDP-17 mutations act to enhance phosphorylation of tau and thus promote neurotoxicity in an in vivo setting. Further, we demonstrate that phosphorylation-dependent excess stabilization of the actin cytoskeleton is a key phosphorylation-dependent mediator of the toxicity of wild-type tau and of all the FTDP-17 mutants tested. Finally, we show that important downstream pathways, including autophagy and the unfolded protein response, are coregulated with neurotoxicity and actin cytoskeletal stabilization in brains of flies expressing wild-type human and various FTDP-17 tau mutants, supporting a conserved mechanism of neurotoxicity of wild-type tau and FTDP-17 mutant tau in disease pathogenesis.SIGNIFICANCE STATEMENT The microtubule protein tau aggregates and forms insoluble inclusion bodies known as neurofibrillary tangles in the brain tissue of patients with a variety of neurodegenerative disorders, including Alzheimer's disease. The tau protein is thus widely felt to play a key role in promoting neurodegeneration. However, precisely how tau becomes toxic is unclear. Here we capitalize on an "experiment of nature" in which rare missense mutations in tau cause familial neurodegeneration and neurofibrillary tangle formation. By comparing the biochemical activities of different tau mutations with their in vivo toxicity in a well controlled Drosophila model system, we find that all mutations tested increase phosphorylation of tau and trigger a cascade of neurotoxicity critically impinging on the integrity of the actin cytoskeleton.
Copyright © 2018 the authors 0270-6474/18/380108-12$15.00/0.

Entities:  

Keywords:  Alzheimer's; Drosophila; tau

Mesh:

Substances:

Year:  2017        PMID: 29138281      PMCID: PMC5761430          DOI: 10.1523/JNEUROSCI.1550-17.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  72 in total

1.  A conditional tissue-specific transgene expression system using inducible GAL4.

Authors:  T Osterwalder; K S Yoon; B H White; H Keshishian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

2.  Genetic modifiers of tauopathy in Drosophila.

Authors:  Joshua M Shulman; Mel B Feany
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

3.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

Review 4.  Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Mark Chao; Akihiko Nunomura; Massimo Tabaton; Robert B Petersen; George Perry; Mark A Smith
Journal:  Antioxid Redox Signal       Date:  2003-10       Impact factor: 8.401

5.  Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation.

Authors:  T Miyasaka; M Morishima-Kawashima; R Ravid; P Heutink; J C van Swieten; K Nagashima; Y Ihara
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  Tau polymerization: role of the amino terminus.

Authors:  T Chris Gamblin; Robert W Berry; Lester I Binder
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

7.  FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions.

Authors:  Benjamin Combs; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-10-18       Impact factor: 3.162

8.  Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.

Authors:  Jormay Lim; Martin Balastik; Tae Ho Lee; Kazuhiro Nakamura; Yih-Cherng Liou; Anyang Sun; Greg Finn; Lucia Pastorino; Virginia M-Y Lee; Kun Ping Lu
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes.

Authors:  Michele Markstein; Chrysoula Pitsouli; Christians Villalta; Susan E Celniker; Norbert Perrimon
Journal:  Nat Genet       Date:  2008-03-02       Impact factor: 38.330

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  16 in total

Review 1.  Associations between atherosclerosis and neurological diseases, beyond ischemia-induced cerebral damage.

Authors:  Dannia Colín-Castelán; Silvio Zaina
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

2.  Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model.

Authors:  Kelly M Lohr; Bess Frost; Clemens Scherzer; Mel B Feany
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

3.  The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity in Vivo.

Authors:  Engie Prifti; Eleni N Tsakiri; Ergina Vourkou; George Stamatakis; Martina Samiotaki; Katerina Papanikolopoulou
Journal:  J Neurosci       Date:  2020-12-17       Impact factor: 6.167

Review 4.  Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease.

Authors:  Fuyuki Kametani; Masato Hasegawa
Journal:  Front Neurosci       Date:  2018-01-30       Impact factor: 4.677

5.  Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics.

Authors:  Farah H Bardai; Dalila G Ordonez; Rachel M Bailey; Matthew Hamm; Jada Lewis; Mel B Feany
Journal:  PLoS Biol       Date:  2018-12-20       Impact factor: 8.029

6.  Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease.

Authors:  Yi-Chen Hsieh; Caiwei Guo; Hari K Yalamanchili; Measho Abreha; Rami Al-Ouran; Yarong Li; Eric B Dammer; James J Lah; Allan I Levey; David A Bennett; Philip L De Jager; Nicholas T Seyfried; Zhandong Liu; Joshua M Shulman
Journal:  Cell Rep       Date:  2019-10-08       Impact factor: 9.423

7.  Pathogenic Tau Causes a Toxic Depletion of Nuclear Calcium.

Authors:  Rebekah Mahoney; Elizabeth Ochoa Thomas; Paulino Ramirez; Henry E Miller; Adrian Beckmann; Gabrielle Zuniga; Radek Dobrowolski; Bess Frost
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

8.  Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies.

Authors:  Wenyan Sun; Hanie Samimi; Maria Gamez; Habil Zare; Bess Frost
Journal:  Nat Neurosci       Date:  2018-07-23       Impact factor: 24.884

9.  Developmental expression of human tau in Drosophila melanogaster glial cells induces motor deficits and disrupts maintenance of PNS axonal integrity, without affecting synapse formation.

Authors:  Enrico M Scarpelli; Van Y Trinh; Zarrin Tashnim; Jacob L Krans; Lani C Keller; Kenneth J Colodner
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

10.  Integrated analysis of the aging brain transcriptome and proteome in tauopathy.

Authors:  Carl Grant Mangleburg; Timothy Wu; Hari K Yalamanchili; Caiwei Guo; Yi-Chen Hsieh; Duc M Duong; Eric B Dammer; Philip L De Jager; Nicholas T Seyfried; Zhandong Liu; Joshua M Shulman
Journal:  Mol Neurodegener       Date:  2020-09-29       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.